clinical trial · NCT07548164
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
Prostate CancerNanoKnife SystemStereotactic Body Radiation Therapy
brief summary
In this study we will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for people with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
started
Apr 16, 2026
primary completion
Apr 16, 2029
completion
Apr 16, 2029
last updated
Apr 23, 2026
official title
Alternative Boost Approaches in Radiation Therapy IRreversible Electroporation Versus RADIAtioN BoosT for Intermediate Risk Prostate Cancer (IRRADIANT)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol